Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
99 found
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester
28 Nov 2022
MMV awards Project of the Year 2021 to GSK for the discovery of GSK484
12 Jul 2022
MMV’s CSO Dr Timothy Wells awarded honorary degree from University of Dundee
23 Jun 2022
Professor Michael Ferguson receives British Society for Parasitology Honorary Membership
04 Mar 2022
MMV launches innovative drug research tool
01 Dec 2021
MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development
31 May 2021
MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling
18 Dec 2020
Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria
19 Aug 2020
MMV awards Project of the Year 2019 to Novartis for the discovery of INE963
13 Jul 2020
MMV launches Malaria
Libre
, a new open source drug discovery programme
07 Jul 2020
ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame
30 Jun 2020
MMV’s Dr James Duffy appointed to RSC Lectureship
19 Jun 2020
Via Grand Challenges Africa, MMV supports eight African drug discovery scientists
23 Sep 2019
MMV awards its Project of the Year 2018 to University of Dundee researchers
10 Jul 2019
Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention
24 Apr 2019
Professor Michael Ferguson receives Knighthood in New Year’s Honours List
14 Jan 2019
Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria
07 Dec 2018
Access to Medicines Index highlights role of collaboration in stimulating R&D
21 Nov 2018
MMV Project of the Year 2017 awarded to Sanofi
10 Jul 2018
MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018
30 Apr 2018
Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period
29 Mar 2018
PLOS Medicine publishes New Malaria Eradication Road Map
01 Dec 2017
Two new MMV-supported research sites inaugurated in Ethiopia
30 Nov 2017
Two MMV partners receive international award
30 Nov 2017
MMV backs training course for study coordinators
01 Nov 2017
MMV hosts international drug discovery meeting in Geneva
26 Oct 2017
Three vivax research teams awarded MMV Project of the Year 2016
10 Oct 2017
MMV discovery partners receive ASBMB awards
09 Oct 2017
Everything you always wanted to know about malaria and more
03 Aug 2017
New publication highlights efficacy of MMV048 against resistant strains of malaria
27 Apr 2017
New antimalarial compound treats and protects in a single dose
29 Mar 2017
MMV partner Prof. David Fidock wins the 2016 Advance Global Australian of the Year Award in Life Sciences
21 Oct 2016
First open source malaria publication describes new way to do drug discovery
14 Sep 2016
PLOS Pathogens
publishes the Malaria Box findings
28 Jul 2016
MMV awards seven endemic-region scientists Challenge Grants to ‘exploit the Pathogen Box’
25 Jul 2016
Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box
31 Mar 2016
MMV launches the Pathogen Box
14 Dec 2015
European regulators grant Pyramax® a revised label
20 Nov 2015
WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project
19 Aug 2015
Pre-clinical assessment of exciting new malaria drug candidate published
16 Jul 2015
OZ439 recognized as a high-impact innovation to transform global health
16 Jul 2015
MMV wins Tim Berners-Lee’s Open Data Innovation Award
10 Jul 2015
MMV awards challenge grants to seven Malaria Box recipients
06 Mar 2015
First Chair of MMV’s ESAC receives knighthood
12 Jan 2015
Three new roads leading to a common pathway
09 Dec 2014
MMV partner Prof. Luiz Carlos Dias receives Santander University Award
13 Nov 2014
MMV organizes international malaria conference in Berlin
01 Jul 2014
MMV and Merck Serono join forces in antimalarial drug discovery
24 Feb 2014
MMV and partners call for compounds to fill the Pathogen Box
18 Feb 2014
Tafenoquine successfully completes Phase IIb clinical trials
19 Dec 2013
State-of-the-art laboratory to study new antimalarials opens in Jakarta
10 Dec 2013
New antimalarial drug target identified
29 Nov 2013
Partners commit to bolstering open source research
27 Nov 2013
MMV signs MoU with Takeda and GHIT (Japan)
11 Nov 2013
MMV partner receives PLOS Accelerating Science Award
23 Oct 2013
First-ever drug compound developed on African soil, an antimalarial, to move to human trials
08 Oct 2013
MMV’s ‘Challenge Model’ creates a buzz in Australia
16 Sep 2013
Potential new class of antimalarials now open source
10 Sep 2013
African research is rising
12 Jul 2013
Quinolones: breathing new life into an old class of compounds to tackle malaria
20 Mar 2013
Pages
1
2
next ›
last »